Drug & Toxic Injury
Personal Injury
Asbestos
Class Actions
Securities Fraud
Commercial Litigation
Gulf Oil Spill
Yaz, Yasmin, and Ocella
Accutane
Hydroxycut
Category : Pharmaceutical Injury
Accutane News Roundup
The news articles rolled in after Seeger Weiss secured an enormous victory for a victim of Accutane.
Associated Press (via ABC): “NJ Jury Awards $25M to Ala. Man in Accutane Suit”
A New Jersey jury has hit the pharmaceutical company that makes Accutane with a $25.16 million judgment…
National Law Journal – “This Time Roche’s Loss to Accutane Suit Is Big, Real Big”
“This drug is awful, and the warnings were inadequate. [Roche] warned about things like pregnancy and those problems, but everything else they really ignored,” said Christopher Seeger of New York’s Seeger Weiss, one of four plaintiffs’ firms that is handling the scores of Accutane lawsuits. The others are Hook Bolton, Beggs & Lane, and Levin Papantonio — all in Pensacola, Fla.
Seeger Weiss wins $25.16 million for Accutane victim
This week Seeger Weiss scored another victory against Accutane, a powerful anti-acne medication that has been linked to several serious side effects, including inflammatory bowel disorder.
On Monday, a nine-person New Jersey jury has found that pharmaceutical maker Hoffman-La Roche Inc. failed to provide an adequate warning of the possible condition to Andrew McCarrell’s prescribing physician, which then led to his development of chronic IBD. Mr. McCarrell, who was 23 at time he took Accutane, developed a severe case of IBD and later had his colon removed. The jury awarded compensatory damages of $25.16 million to Andy, now in his thirties.
Hoffman-La Roche faces as many as 800 cases around the country. Seeger Weiss has won 5 consecutive verdicts against Roche since 2005.
Victory in bellwether pain pump lawsuit
Injured victim Matthew Beale, a 38-year-old father whose cartilage in his right shoulder disappeared after a pain pump was used following shoulder surgery, and his wife were awarded $5.5 million in an Oregon court last week – the first of hundreds of similar pain pump cases set to go to trail. Oregon Live details the pain Mr. Beale experienced after I-Flow, a pain pump manufacturer, encouraged doctors to employ their products in joint surgeries even after the FDA repeatedly refused to approve those types of uses.
Seeger Weiss LLP is part of the litigation group working in coordination to bring these cases to court across the country. The Oregon case is expected to set the trend for upcoming cases, and gives many pain-pump victims hope for relief and justice.
Following this giant victory for pain pump victims across the country, the New York Times follows up with a piece on pain pump studies.
Doctor who faked favorable Vioxx research charged with fraud
Washington Post: Federal prosecutors announced Thursday that they have filed a health care fraud charge against a doctor accused of faking research for a dozen years in published studies that suggested after-surgery benefits from painkillers including Vioxx and Celebrex.
Court documents indicate that Dr. Scott Reuben, an anesthesiologist, has agreed to plead guilty in exchange for prosecutors recommending a more lenient sentence of up to 10 years imprisonment, a $250,000 fine and forfeiture of assets worth at least $50,000 that Reuben received for the research.
Prosecutors allege the former chief of acute pain at Baystate Medical Center in Springfield sought and received research grants from pharmaceutical companies but never performed the studies. He fabricated patient data and submitted information to anesthesiology journals that unwittingly published it, court documents allege.
US News: Fosamax overprescribed in women
US News: According to the National Osteoporosis Foundation, about 10 million Americans have osteoporosis, 80 percent of them women, but an additional 34 million have “low bone mass” that puts them at increased risk. Sally Field is in the former group, but many women in the latter category, experts contend, are being unnecessarily treated with bisphosphonate drugs like Boniva, Fosamax, or Actonel.
Yaz, Yasmin, Ocella Litigation Consolidated in Pennsylvania
On September 16, Judge Sandra Mazer Moss of the Philadelphia Court of Common Pleas consolidated all of the lawsuits filed in Philadelphia that involve Bayer’s popular prescription contraceptives: Yaz and Yasmin. Ocella, the generic equivalent of Yasmin, is manufactured by Barr Laboratories.
Recent reports suggest that these prescription medications could be putting millions of young women at risk of serious side effects, including stroke, heart attack, blood clots, deep vein thrombosis, pulmonary embolism, and even death. A recent study published by the British Medical Journal demonstrated that birth control products containing the active ingredient contained in Yaz, Yasmin, and Ocella—drospirenone—carried a risk of blood clots nearly double that of other birth control medications. Other reports have associated drospirenone with an increased risk of gall bladder disease, resulting in removal.
Subscribe to our RSS